MedPath

A prospective multicenter study of patients treated with molecular target therapy for hepatocellular carcinoma

Not Applicable
Recruiting
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000010085
Lead Sponsor
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who do not give informed consent (2) Patients who is not thought to be eligible for participation in this study by researchers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Antitumor effects and occurrence of adverse events in molecular target therapy for hepatocellular carcinoma
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath